A. Nazlı Başak

2.8k total citations
56 papers, 864 citations indexed

About

A. Nazlı Başak is a scholar working on Neurology, Molecular Biology and Genetics. According to data from OpenAlex, A. Nazlı Başak has authored 56 papers receiving a total of 864 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Neurology, 22 papers in Molecular Biology and 19 papers in Genetics. Recurrent topics in A. Nazlı Başak's work include Amyotrophic Lateral Sclerosis Research (16 papers), Neurogenetic and Muscular Disorders Research (15 papers) and Genetic Neurodegenerative Diseases (13 papers). A. Nazlı Başak is often cited by papers focused on Amyotrophic Lateral Sclerosis Research (16 papers), Neurogenetic and Muscular Disorders Research (15 papers) and Genetic Neurodegenerative Diseases (13 papers). A. Nazlı Başak collaborates with scholars based in Türkiye, United States and Germany. A. Nazlı Başak's co-authors include Mehmet Ozansoy, Kaya Bilgüvar, Murat Günel, Ghazi Omar Tadmouri, Onur Emre Onat, Tayfun Özçelık, Haluk Topaloğlu, Üner Tan, Süleyman Gülsüner and Meli̇ha Tan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Annals of Neurology.

In The Last Decade

A. Nazlı Başak

53 papers receiving 844 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Nazlı Başak Türkiye 17 415 306 247 154 121 56 864
Alice B. Schindler United States 15 607 1.5× 202 0.7× 396 1.6× 201 1.3× 104 0.9× 37 1.0k
Amr Al‐Saif United States 12 520 1.3× 198 0.6× 164 0.7× 104 0.7× 124 1.0× 14 1.0k
Martine Therrien Canada 12 355 0.9× 318 1.0× 184 0.7× 223 1.4× 29 0.2× 17 808
Marie Bernadette Delisle France 15 457 1.1× 240 0.8× 125 0.5× 157 1.0× 39 0.3× 30 898
Wei‐Ming Duan China 17 421 1.0× 122 0.4× 276 1.1× 62 0.4× 140 1.2× 32 871
Lorenzo Nanetti Italy 15 400 1.0× 270 0.9× 491 2.0× 95 0.6× 52 0.4× 51 721
Silvia Rathke‐Hartlieb Germany 9 554 1.3× 317 1.0× 325 1.3× 159 1.0× 48 0.4× 9 979
Senlin Li United States 19 443 1.1× 295 1.0× 300 1.2× 39 0.3× 69 0.6× 30 1.1k
Young Bin Hong South Korea 18 442 1.1× 177 0.6× 542 2.2× 103 0.7× 46 0.4× 56 994
Barry A. Chioza United Kingdom 20 551 1.3× 265 0.9× 182 0.7× 167 1.1× 222 1.8× 39 1.1k

Countries citing papers authored by A. Nazlı Başak

Since Specialization
Citations

This map shows the geographic impact of A. Nazlı Başak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Nazlı Başak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Nazlı Başak more than expected).

Fields of papers citing papers by A. Nazlı Başak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Nazlı Başak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Nazlı Başak. The network helps show where A. Nazlı Başak may publish in the future.

Co-authorship network of co-authors of A. Nazlı Başak

This figure shows the co-authorship network connecting the top 25 collaborators of A. Nazlı Başak. A scholar is included among the top collaborators of A. Nazlı Başak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Nazlı Başak. A. Nazlı Başak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gautam, Mukesh, et al.. (2025). Exosome Proteomics of SOD1 D90A Mutation Suggest Early Disease Mechanisms, and FN1 as a Biomarker. Annals of Clinical and Translational Neurology. 13(1). 131–143. 1 indexed citations
2.
Başak, A. Nazlı, et al.. (2024). Successful infliximab treatment in siblings with Netherton syndrome: Unveiling a novel SPINK5 gene variant and literature review. Australasian Journal of Dermatology. 65(3). e45–e49. 2 indexed citations
3.
Ugga, Lorenzo, Mirco Cosottini, Ivana Ricca, et al.. (2024). MRI‐ARSACS: An Imaging Index for Autosomal Recessive Spastic Ataxia of Charlevoix‐Saguenay (ARSACS) Identification Based on the Multicenter PROSPAX Study. Movement Disorders. 39(8). 1343–1351. 2 indexed citations
4.
Çakar, Arman, et al.. (2022). Phenotypical spectrum of SACS variants: Neuromuscular perspective of a complex neurodegenerative disorder. Acta Neurologica Scandinavica. 145(5). 619–626. 2 indexed citations
5.
Sever, Belgin, Halil I. Ciftci, Hasan DeMi̇rci̇, et al.. (2022). Comprehensive Research on Past and Future Therapeutic Strategies Devoted to Treatment of Amyotrophic Lateral Sclerosis. International Journal of Molecular Sciences. 23(5). 2400–2400. 49 indexed citations
7.
Başak, A. Nazlı, Onur Emre Onat, Kaya Bilgüvar, et al.. (2021). The genetic structure of the Turkish population reveals high levels of variation and admixture. Proceedings of the National Academy of Sciences. 118(36). 47 indexed citations
8.
Çakar, Arman, Erdi Şahin, Bedia Samancı, et al.. (2021). Cerebellar ataxia, neuropathy and vestibular areflexia syndrome (canvas): an important cause of late-onset ataxia with unique clinical features. Acta Neurologica Belgica. 122(4). 939–945. 2 indexed citations
9.
Samancı, Bedia, et al.. (2020). A novel PNPLA6 mutation in a Turkish family with intractable Holmes tremor and spastic ataxia. Neurological Sciences. 42(4). 1535–1539. 11 indexed citations
10.
11.
12.
Akçimen, Fulya, Atay Vural, Hacer Durmuş, et al.. (2019). A novel homozygous FBXO38 variant causes an early-onset distal hereditary motor neuronopathy type IID. Journal of Human Genetics. 64(11). 1141–1144. 9 indexed citations
13.
Vural, Seçil, Atay Vural, Fulya Akçimen, et al.. (2018). Clinical and molecular characterization and response to acitretin in three families with Sjögren‐Larsson syndrome. International Journal of Dermatology. 57(7). 843–848. 6 indexed citations
14.
Corrado, Lucia, Cinzia Tiloca, Alessandra Bagarotti, et al.. (2018). Characterization of the c9orf72 GC-rich low complexity sequence in two cohorts of Italian and Turkish ALS cases. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 19(5-6). 426–431. 2 indexed citations
15.
Akçimen, Fulya, Kemal S. Türker, Hakkı Dalçık, et al.. (2018). Assessment of the corticospinal fiber integrity in mirror movement disorder. Journal of Clinical Neuroscience. 54. 69–76. 3 indexed citations
16.
Tunca, Ceren, Fulya Akçimen, Aslı Gündoğdu-Eken, et al.. (2018). ERLIN1 mutations cause teenage-onset slowly progressive ALS in a large Turkish pedigree. European Journal of Human Genetics. 26(5). 745–748. 24 indexed citations
17.
Gispert, Suzana, Sylvia Torres-Odio, Ewa Damrath, et al.. (2016). Search for SCA2 blood RNA biomarkers highlights Ataxin-2 as strong modifier of the mitochondrial factor PINK1 levels. Neurobiology of Disease. 96. 115–126. 29 indexed citations
18.
Halbach, Melanie V., et al.. (2015). Both Ubiquitin Ligases FBXW8 and PARK2 Are Sequestrated into Insolubility by ATXN2 PolyQ Expansions, but Only FBXW8 Expression Is Dysregulated. PLoS ONE. 10(3). e0121089–e0121089. 23 indexed citations
19.
Gülsüner, Süleyman, Ayşe B. Tekinay, Katja Doerschner, et al.. (2011). Homozygosity mapping and targeted genomic sequencing reveal the gene responsible for cerebellar hypoplasia and quadrupedal locomotion in a consanguineous kindred. Genome Research. 21(12). 1995–2003. 51 indexed citations
20.
Başak, A. Nazlı & Şükrü Tüzmen. (2010). Genetic Predisposition to β-Thalassemia and Sickle Cell Anemia in Turkey: A Molecular Diagnostic Approach. Methods in molecular biology. 700. 291–307. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026